Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect

The Journal of Clinical Investigation
E A KvittingenR Berger

Abstract

Two Norwegian patients with chronic tyrosinemia type I showed > 50% residual fumarylacetoacetase activity in liver samples obtained during liver transplantation. The enzyme characteristics of both patients were comparable with those of a normal control. Immunohistochemistry on liver sections from these patients and from three other Norwegian tyrosinemia patients revealed a mosaicism of fumarylacetoacetase immunoreactivity corresponding completely or partly to some of the regenerating nodules. This appearance of enzyme protein is presumably induced by the disease process. The mechanism involved remains unclear and could be caused by a genetic alteration, regained translation of messenger RNA, or to enhanced stability of an abnormal enzyme.

References

Mar 1, 1976·The Journal of Pediatrics·A G WeinbergH G Worthen
Jan 1, 1991·Journal of Inherited Metabolic Disease·E A Kvittingen
Sep 1, 1991·Mutation Research·A A Morley
Oct 31, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·R BergerG P Smith
Aug 4, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·A GrenierO Mamer
Sep 1, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·E A KvittingenO Stokke

❮ Previous
Next ❯

Citations

Apr 16, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S Gupta
Jun 10, 2006·Journal of Inherited Metabolic Disease·Markus Grompe
Mar 1, 1997·Molecular Medicine Today·M A Kay, N Fausto
Aug 9, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nicole K PaulkMarkus Grompe
Mar 1, 1996·Nature Genetics·J M Wilson
Oct 3, 2002·Nature Reviews. Genetics·Hagop Youssoufian, Reed E Pyeritz
Jul 21, 2011·British Medical Bulletin·Massoud VosoughHossein Baharvand
Oct 9, 2002·Clinical Obstetrics and Gynecology·Alan W Flake
Aug 6, 2010·Journal of Virology·Sam Laurel StephenStefan Kochanek
Oct 22, 2003·Journal of Medical Genetics·R Hirschhorn
Oct 1, 1994·The Journal of Clinical Investigation·E A KvittingenP Brandtzaeg
Dec 17, 2009·Orphanet Journal of Rare Diseases·David CassimanJaak Jaeken
Jul 3, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Hyung-Doo ParkYong-Wha Lee
Oct 15, 2013·Journal of Medical Genetics·Rui LiJ Brent Richards
Oct 16, 1999·Proceedings of the National Academy of Sciences of the United States of America·K ManningM Grompe
Mar 11, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Y T BliksrudE A Kvittingen
Nov 13, 2003·Médecine sciences : M/S·Anne BergeronRobert M Tanguay
Nov 9, 2010·Clinics in Liver Disease·Angshumoy Roy, Milton J Finegold
Dec 6, 2011·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Vanessa SauerHartmut H J Schmidt
Feb 11, 2011·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·S Harvey Mudd
Jan 27, 1998·Hematology/oncology Clinics of North America·G M KupferA D D'Andrea
Apr 2, 2002·Best Practice & Research. Clinical Haematology·A W Flake
Jun 11, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Demetri MerianosAlan W Flake
Aug 15, 1998·Molecular Genetics and Metabolism·J PoudrierR M Tanguay
Oct 12, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Patrice K HeldMarkus Grompe
Aug 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M EspeelF Roels
Apr 8, 2006·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·C Ronald Scott
Oct 1, 2007·Expert Review of Gastroenterology & Hepatology·Tuan Huy Nguyen, Nicolas Ferry
Dec 29, 2000·Annals of Medicine·S T PitkänenM Heikinheimo
Aug 11, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Karl-Dimiter BissigXinxin Ding
Sep 5, 1998·Journal of Inherited Metabolic Disease·M GrompeM Finegold
Jul 29, 2016·Science Translational Medicine·Raymond D HickeyScott L Nyberg
Jan 1, 1996·Human Mutation·H RootweltE A Kvittingen
Sep 5, 1998·Journal of Inherited Metabolic Disease·E Holme, S Lindstedt
Dec 16, 1998·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·R Jaffe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.